The cost of immunotherapy for lung cancer in Spain typically ranges from $30,000 to $60,000. Prices vary depending on the specific immunotherapy drug (such as pembrolizumab or nivolumab), the number of treatment cycles, and whether care is delivered in a public or private hospital. In the United States, the average cost is $90,000 (per ASCO). This means patients in Spain can expect savings of about 50% compared to the U.S.
Spanish clinics usually include the cost of the immunotherapy medication, pre-treatment evaluations, administration by an oncology team, routine lab monitoring, and scheduled follow-up visits. In the U.S., drug costs, infusion fees, and follow-up care are often billed separately. Always confirm what’s included in the treatment plan with your chosen clinic.
Why choose Spain for immunotherapy for lung cancer?
Access advanced Immunotherapy for lung cancer solutions in trusted clinics .
| Turchia | Austria | Spain | |
| Immunotherapy for lung cancer | da $18,000 | da $30,000 | da $30,000 |
Revisionato medicalmente da
Fahad MawloodBookimed non aggiunge costi extra ai prezzi di Immunotherapy for lung cancer. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica per la tua Immunotherapy for lung cancer al tuo arrivo.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali in Immunotherapy for lung cancer e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di Immunotherapy for lung cancer.
Day 1 - Arrival
Day 2 - Pre-operation
Day 3 - Immunotherapy
Day 4 - Post-operation
Week 1 - Rehabilitation
Week 2 - Rehabilitation
Please keep in mind that each patient"s journey is unique and can vary. Always follow the specific advice provided by your medical team.
Dr. Vergés is a distinguished ophthalmologist with a PhD from Harvard and multiple national research awards, focusing on advanced eye care.
Leading expert in immunotherapy for lung cancer – Dr. Felip integrates novel immunotherapies into treatment protocols at Hospital Quiron Barcelona.
Dr. Joan Albanell Mestres is a leading oncologist who specializes in breast cancer. He earned his MBBS from the University Autónoma de Barcelona in 1989. He leads the breast cancer program at HM Delfos and oversees Oncology services at Clin del Mar in Spain.
Dr. Albanell has published 120 scientific articles, with over 9,000 citations. He directs cancer research at Del Mar. He is also an active member of GEICAM, CIBERONC, AIECA, and SEOM. He regularly contributes to important oncology research.